BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6511990)

  • 1. Time-dependent absorption of theophylline in man.
    Watanabe H; Nakano S; Nagai K; Ogawa N
    J Clin Pharmacol; 1984; 24(11-12):509-14. PubMed ID: 6511990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronopharmacokinetics of theophylline after sustained release and intravenous administration to adults.
    Jonkman JH; van der Boon WJ; Balant LP; Schoenmaker R; Holtkamp A
    Eur J Clin Pharmacol; 1984; 26(2):215-22. PubMed ID: 6723760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.
    Fixley M; Shen DD; Azarnoff DL
    Am Rev Respir Dis; 1977 Jun; 115(6):955-62. PubMed ID: 262107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of theophylline and circadian rhythm].
    Pradalier A; Dry J; Flouvat B; Decourt S; Fodor F
    Pathol Biol (Paris); 1982 Dec; 30(10):851-4. PubMed ID: 6760063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of once-daily theophylline dose following the morning versus evening administration.
    Trnavská Z; Vondra V; Elis J
    Arzneimittelforschung; 1989 Sep; 39(9):1149-51. PubMed ID: 2590267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and diurnal variation in absorption of sustained release theophylline in asthmatic children.
    Coulthard KP; Birkett DJ; Lines DR; Grgurinovich N; Grygiel JJ
    Eur J Clin Pharmacol; 1983; 25(5):667-72. PubMed ID: 6686557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of diurnal changes in the disposition of theophylline.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Oct; 16(4):413-6. PubMed ID: 6684947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of theophylline in children following the administration of doses generally recommended: new dosage regimen required.
    Selvig K; Holmen TL; Aas K; Rugstad HE; Bjerve KS
    Acta Paediatr Scand; 1979 May; 68(3):435-9. PubMed ID: 443044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and relative bioavailability of oral theophylline capsules.
    Lesko LJ; Canada AT; Eastwood G; Walker D; Brousseau DR
    J Pharm Sci; 1979 Nov; 68(11):1392-4. PubMed ID: 583162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal variation in the disposition of theophylline and its metabolites.
    St-Pierre MV; Spino M; Isles AF; Tesoro A; MacLeod SM
    Clin Pharmacol Ther; 1985 Jul; 38(1):89-95. PubMed ID: 4039998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic studies of theophylline in dogs.
    McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
    J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cimetidine decreases theophylline clearance.
    Jackson JE; Powell JR; Wandell M; Bentley J; Dorr R
    Am Rev Respir Dis; 1981 Jun; 123(6):615-7. PubMed ID: 7023306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of rifampin on theophylline kinetics.
    Boyce EG; Dukes GE; Rollins DE; Sudds TW
    J Clin Pharmacol; 1986; 26(8):696-9. PubMed ID: 3793963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1988 Feb; 40(2):101-5. PubMed ID: 2897439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioavailability of theophylline in horses.
    Errecalde JO; Button C; Baggot JD; Mulders MS
    J Vet Pharmacol Ther; 1984 Dec; 7(4):255-63. PubMed ID: 6512916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
    Hibberd SG; Alveyn C; Coombes EJ; Holgate ST
    Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bioavailability of theophylline after oral administration of a retard preparation of theophylline-ethylenediamine and the influence of 15-day ingestion on elimination kinetics after i.v. injection (author's transl)].
    Wiessmann KJ
    Arzneimittelforschung; 1980; 30(2):329-32. PubMed ID: 7378114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.